I'm really getting frustrated. I don't understand why they would even present to this target market with no new information and no relevant investment data and perhaps not even having a need or strategy to attract financing from this group. It seems financing will be(is) Chinese sourced plus the Eastern $ as I recall. I like this (the Chinese and continued Eastern) votes of confidence somewhat.

So the new investors must see merit in the epigenetics making SOC drugs effective for a longer period(I was very excited by this strategy but I don't see big investors(BPs) chomping at the bit other than the Pfizer/TNBC trial which has years to spin out before we see some valuable potential). The financial/investment aspects were not even addressed in this presentation.

This is very, very, very disappointing. I really hope posters in a better mood, science types and business types will chime in and show me the progression from the last presentation.

I apologize for my frustrated rant but I am insensed by this (but it is science and it is what it is). At this stage all I want is liquidity so that I can reduce my position. I may regret this in 5 years but now if I could sell shares at least I would be less frustrated.

GLTA

Toinv